Industry
IVD Sector in India Shows Stable Growth and Exhibits Potential
According to a new report, the in vitro diagnostic testing sector in India is estimated to have reached USB 782 million in 2015 and modernizing healthcare infrastructure and steady migration from manual to automated processes will support additional growth. More...31 Jan 2016
Thermo Fisher to Acquire Affymetrix, Strengthens Biosciences Leadership
Thermo Fisher Scientific and Affymetrix have announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of Affymetrix for USD 14.00 per share in cash, representing purchase price of approximately USD 1.3 billion More...12 Jan 2016
Top Five IVD Sector Trends of 2015 Announced
Among the in vitro diagnostic testing trends in 2015 were smaller molecular instruments, better information technology systems, and progress on use of sequencing in clinical medicine. These and additional findings were based on research covered in three new healthcare market reports. More...21 Dec 2015
Challenge to Reduce Sexually Transmitted Disease Infections Spurs Growth in IVD Sector
Nearly one out of every five dollars earned in infectious disease testing is from a test for sexually transmitted infections or women’s health test, according to a new healthcare market research report. More...20 Dec 2015
Growth Continues in Infectious Disease Diagnostics
Global testing for infectious diseases has reached USD 16.8 Billion and the segment continues to expand from demand, growing infrastructure in emerging nations, and intense competition, according to a new healthcare market study. More...24 Nov 2015
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
In Other News
Distribution Agreement Reached for Multiplexed Assay Platforms
Enhanced IT Propels Clinical Laboratory Services Sector
Erba Mannheim Acquires Maxmat for Diagnostics Analyzers and Advanced Development
Diagnostic Company Acquisition to Ease Market Entry and Shorten Development Time for New Tests
Supply Agreement to Boost Molecular Diagnostic Testing in Scandinavia
Clinical Applications Transforming Flow Cytometry Sector
Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer
Distribution Agreement to Improve Automated Hemostasis Diagnostics
Innovative Microbial Diagnostics Developer Acquired by Biomedical Giant
Alere Strengthens Core Strategy Through Two New Transactions
Cancer Genetics Expands Access to Proprietary Diagnostics Through Agreement with Harvard Pilgrim
QIAGEN Expands Diagnostics Menu in Partnership with Seegene
Next Generation Sequencing Provides Responsiveness for Identifying Resistant Pathogens
Hitachi High-Tech and QIAGEN Partner to Advance Diagnostics
Cloud-Based Systems Becoming Key Pillar in eHealth Strategy
Advanced NGS Partnership Paves Way for More Accessible Personalized Medicine in Cancer
New Point of Care Test for Anemia Developed
Main Factors Driving Revenue Growth in Clinical Chemistry Identified
Bio-Rad Grants Beckman Coulter Exclusive Distribution for Two Infectious Disease Tests
Partnership to Offer New Coagulation Testing Solutions Worldwide
Clinical Lab Automation Sector at USD 5.4 Billion and Growing
Beyond Brazil, Latin American IVD Sector Grows
Improved Ebola IVD Tests Continue to Face Challenges
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.